Vanguard Fiduciary Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$461M Sell
1,193,336
-49,108
-4% -$18.2M 0.1% 157
2026
Q1
$364M Buy
+1,242,444
New +$408M 0.09% 200

Other funds holding ELV

Vanguard Fiduciary Trust's ELV Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Elevance Health (ELV) stake by 4% in Q2 2026, selling an estimated $18.2M and leaving 1,193,336 shares worth $461M. The position accounts for 0.1% of the portfolio, ranked #157.

Vanguard Fiduciary Trust first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,586 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,193,336 shares of Elevance Health worth $461M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 49,108 Elevance Health shares in Q2 2026, an estimated $18.2M.
  • Elevance Health made up 0.1% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #157 holding.
  • Vanguard Fiduciary Trust first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
  • 1,586 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.